KRISTIE NOLTA: Open Payments
NPI 1558818997 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167 in 7 payments from 6 companies in 2025. Trend: 2023 $250 · 2024 $161 · 2025 $167
Food & beverage: $167
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $53 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Verona Pharma, Inc. | 1 | $23 |
| Insmed, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $15 |
Products named: DUPIXENT, UPTRAVI, TEZSPIRE, Ohtuvayre, Arikayce, ZEPBOUND.
Industry payments across WA — which companies pay providers there.
